BIOMARIN PHARMACEUTICAL INC.
Last · —$55.14+0.76 (+1.40%)live · yahoo · 0s ago
Market cap$11.05B—
P/E · TTM154fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
| Revenue | $3.4B |
|---|---|
| Operating income | $240.6M |
| Net income | $150.3M |
| Free cash flow | $339.0M |
| Operating margin | 7.1% |
| Net margin | 4.4% |
| Return on equity | 2.4% |
| Period | TTM 2026-06-30 |
Loading chart…
Upcoming earnings
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
$0.95
Est. revenue
1.0B
Earnings transcripts
- Issuer webcast
Webcast of Q2 2026, Online link
BIOMARIN PHARMACEUTICAL INC.
- Issuer webcast
Q1 2026 webcast
BIOMARIN PHARMACEUTICAL INC.
- Issuer webcast
Q4 2025 webcast
BIOMARIN PHARMACEUTICAL INC.
- Issuer webcast
Q2 2026 webcast
BIOMARIN PHARMACEUTICAL INC.
- Issuer webcast
Q3 2025 webcast
BIOMARIN PHARMACEUTICAL INC.
- Issuer webcast
Q2 2025 webcast
BIOMARIN PHARMACEUTICAL INC.
Documents
FormReporting forFiledFlags